Foley Partner Courtenay Brinckerhoff was quoted in an article that appeared in The New York Times on December 17, 2010 titled “Court Backs Patents for Diagnostic Tests.” Brinckerhoff discusses a Court of Appeals for the Federal Circuit ruling which upholds that diagnostic tests used to determine whether a patient is getting the proper dose of a medicine can be patented. She states that the decision will be welcomed by those working in personalized medicine and may help improve both the clinical efficacy and cost-efficiency of therapeutic treatment.
People
Related News
14 February 2025
In the News
Brian Wheeler Joins Podcast to Discuss Legal Journey
Foley & Lardner LLP partner Brian Wheeler joined the Hsu Untied podcast to discuss his legal career.
14 February 2025
In the News
Pavan Agarwal Featured in Leadership Q&A – 'Reflecting our firm’s core values drives me to do my best'
Foley & Lardner LLP partner Pavan Agarwal is featured by Law.com for his career journey, legal practice, and leadership in the article, “How I Made Practice Group Chair: ‘Keep Listening and Keep Learning,’ Says Pavan Agarwal of Foley & Lardner.”
14 February 2025
In the News
Judith Waltz on Trump Administration Deregulation Order, Impact on CMS
Foley & Lardner LLP partner Judith Waltz commented on the Trump administration's executive order requiring federal agencies cut ten regulations for each newly created one in the Modern Healthcare article, "CMS may evade Trump's sweeping deregulation order."